Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Craig

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Australasian Physical & Engineering Sciences in Medicine|January 5, 2002
Recommendations for a mammography quality assurance programA R Craig, J C Heggie, I D McLean, et al.
Clinical Chemistry|September 1, 1984
Novel shell/core particles for automated turbidimetric immunoassaysW J Litchfield, A R Craig, W A Frey, et al.
Clinical Chemistry|July 1, 1991
Stabilization of turbidimetric immunoassay by covalent coupling of antibody to latex particlesH Thakkar, C L Davey, E A Medcalf, et al.
Clinical Chemistry|January 1, 1997
Development and validation of a particle-enhanced turbidimetric inhibition assay for urine albumin on the Dade aca analyzerH Thakkar, D J Newman, P Holownia, et al.
Clinical Chemistry|January 24, 1998
Kinetics and proposed mechanism of the reaction of an immunoinhibition, particle-enhanced immunoassayJ C Thompson, A R Craig, C L Davey, et al.
Clinical Chemistry|March 3, 1999
Automated homogeneous immunoassay for gentamicin on the dimension clinical chemistry systemT Q Wei, V P Chu, A R Craig, et al.
American Journal of Hematology|March 8, 2013
Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic-phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitorsJ Cortes, R Digumarti, P M Parikh, et al.
Clinical Chemistry|September 1, 1985
A quantitative automated immunoassay for fibrinogen/fibrin degradation productsR S Schifreen, G S Cembrowski, D C Campbell, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Australasian Physical & Engineering Sciences in Medicine|January 5, 2002
Recommendations for a mammography quality assurance programA R Craig, J C Heggie, I D McLean, et al.
Clinical Chemistry|September 1, 1984
Novel shell/core particles for automated turbidimetric immunoassaysW J Litchfield, A R Craig, W A Frey, et al.
Clinical Chemistry|July 1, 1991
Stabilization of turbidimetric immunoassay by covalent coupling of antibody to latex particlesH Thakkar, C L Davey, E A Medcalf, et al.
Clinical Chemistry|January 1, 1997
Development and validation of a particle-enhanced turbidimetric inhibition assay for urine albumin on the Dade aca analyzerH Thakkar, D J Newman, P Holownia, et al.
Clinical Chemistry|January 24, 1998
Kinetics and proposed mechanism of the reaction of an immunoinhibition, particle-enhanced immunoassayJ C Thompson, A R Craig, C L Davey, et al.
Clinical Chemistry|March 3, 1999
Automated homogeneous immunoassay for gentamicin on the dimension clinical chemistry systemT Q Wei, V P Chu, A R Craig, et al.
American Journal of Hematology|March 8, 2013
Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic-phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitorsJ Cortes, R Digumarti, P M Parikh, et al.
Clinical Chemistry|September 1, 1985
A quantitative automated immunoassay for fibrinogen/fibrin degradation productsR S Schifreen, G S Cembrowski, D C Campbell, et al.
Pageof 3